tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Amanda Murphy, 15 are a BUY (100%).
Analyst Amanda Murphy, carries an average stock price target met ratio of 61.9% that have a potential upside of 31.04% achieved within 128 days. Previously, Amanda Murphy worked at BTIG.
Amanda Murphy’s has documented 31 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 04-Nov-2021.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 4/2/2020. The price target of $22 was fulfilled within 62 days with a profit of $10.1 (84.87%) receiving and performance score of 13.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Sep-2025
$32
$3.65 (12.87%)
$25
Buy Since 07-Oct-2020
$34
$5.65 (19.93%)
$25
15 days ago
(22-Sep-2026)
16/21 (76.19%)
$5.94 (21.17%)
163
Buy Since 08-May-2023
$27.5
$-0.85 (-3.00%)
$20
2 months 3 days ago
(04-Aug-2026)
17/17 (100%)
$2.95 (12.02%)
317
Hold Since 09-Sep-2020
$22
$-6.35 (-22.40%)
$20
2 months 7 days ago
(30-Jul-2026)
13/19 (68.42%)
$-2.18 (-9.02%)
469
Buy Since 06-Aug-2025
$28
$-0.35 (-1.23%)
$21
2 months 7 days ago
(30-Jul-2026)
3/3 (100%)
$3.82 (15.80%)
56
